Teng Zhang
Wuhu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo.
Journal: Biochemical pharmacology
Published: December 18, 2023
Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro.
Journal: Frontiers in pharmacology
Published: November 30, 2023
Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis.
Journal: European journal of pharmacology
Published: October 18, 2023
Protective effects of metformin on pancreatic β-cell ferroptosis in type 2 diabetes in vivo.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2023
Metformin alleviates glucolipotoxicity-induced pancreatic β cell ferroptosis through regulation of the GPX4/ACSL4 axis.
Journal: European journal of pharmacology
Published: May 19, 2023
LncRNA HEM2ATM improves obesity-associated adipose tissues meta-inflammation and insulin resistance by interacting with heterogeneous nuclear ribonucleoprotein U.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 01, 2022
M6 A demethylase fat mass and obesity-associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1.
Journal: Cancer science
Published: February 24, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026